Skip to main content

Table 3 Multivariate analysis of parameters with bRFS

From: Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml

Factors

Hazards ratio (95% CI)

p value

Pathologic tumor stage

 

0.003

T1-2

Reference

 

T3-4

3.512 (1.535-8.037)

 

Preoperative PSA (ng/ml)

 

0.177

< 10

Reference

 

≥ 10

1.566 (0.816-3.006)

 

PSADT (months)

 

0.272

< 7

Reference

 

≥ 7

0.686 (0.350-1.344)

 

RT dose (Gy)

 

0.357

< 64

Reference

 

≥ 64

0.712 (0.345-1.469)

 
  1. Abbreviations: bRFS = biochemical relapse-free survival, PSA = prostate-specific antigen, PSADT = prostate-specific antigen doubling time, RT = radiotherapy, RP = radical prostatectomy, CI = confidence interval
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us